Similarly to the use of the AFP promoter and enhancer for HCC, prostate-specific antigen promoters have been used for prostate cancer (19), while E2F and telomerase reverse transcriptase promoters are used for various types of tumors (20,21). The gene discussed is KLK3; the disease is hepatocellular carcinoma.